Journey Medical (DERM) EBITDA Margin (2020 - 2026)
Journey Medical (DERM) posted EBITDA Margin of 9.37% for Q1 2026, down 240.14% on a QoQ basis from 2.76% in Q4 2025, and up 1593.0% year-over-year from 0.55% in Q1 2025.
Journey Medical (DERM) EBITDA Margin (2020 - 2026) Analysis & Trends
Journey Medical's EBITDA Margin history runs 7 years deep, the most recent figure standing at 9.37% for Q1 2026.
- Quarterly EBITDA Margin rose 1593.0% year-over-year to 9.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.9% (up 261.0% YoY) and the FY2025 annual result came in at 13.21%, up 1160.0% from the prior year.
- EBITDA Margin was 9.37% for Q1 2026 at Journey Medical, down from 2.76% in the prior quarter.
- Across five years, EBITDA Margin topped out at 49.93% in Q3 2023 and bottomed at 78.59% in Q1 2023.
- A 5-year average of 24.55% and a median of 19.7% in 2024 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 10883 bps in 2023, while the deepest fall reached 7432 bps in 2023.
- Journey Medical's EBITDA Margin stood at 62.78% in 2022, then surged by 78 bps to 13.79% in 2023, then soared by 228 bps to 17.7% in 2024, then slumped by 116 bps to 2.76% in 2025, then slumped by 240 bps to 9.37% in 2026.
- Business Quant data shows DERM's EBITDA Margin at 9.37% in Q1 2026, 2.76% in Q4 2025, and 8.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -9.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.37% |
| Dec 31, 2025 | -2.76% |
| Sep 30, 2025 | -8.98% |
| Jun 30, 2025 | -19.16% |
| Mar 31, 2025 | -25.30% |
| Dec 31, 2024 | 17.70% |
| Sep 30, 2024 | -19.78% |
| Jun 30, 2024 | -19.70% |
| Mar 31, 2024 | -77.44% |
| Dec 31, 2023 | -13.79% |
| Sep 30, 2023 | 49.93% |
| Jun 30, 2023 | -45.12% |
| Mar 31, 2023 | -78.59% |
| Dec 31, 2022 | -62.78% |
| Sep 30, 2022 | -58.90% |
| Jun 30, 2022 | -39.05% |
| Mar 31, 2022 | -4.27% |
| Dec 31, 2021 | -51.70% |
| Sep 30, 2021 | -64.49% |
| Jun 30, 2021 | -90.02% |